AA Yakovlev, SS Suleimanova*, DL Sulima, VN Koryagin, NM Kravchuk and VA Larionov
Department of Infectious Disease, the Pavlov First Saint Petersburg, State Medical University, Russian Federation
*Corresponding Author: SS Suleimanova, Department of Infectious Disease, the Pavlov First Saint Petersburg, State Medical University, Russian Federation.
Received: January 28, 2022; Published: February 09, 2022
A female patient Sh. aged 58, was observed in the EXCLUSIVE clinic with a diagnosis
Chronic HCV-infection 1b genotype
HCV-associated chronic steatohepatitis (S2/0.50) with moderate necroinflammatory activity (A1/0.35) and minimal fibrosis (F1/0.33).
Citation: SS Suleimanova., et al. “Coronavirus Disease (COVID-19) in a Patient with Chronic HCV-Infection Receiving Direct-Acting Antiviral Agents". Acta Scientific Gastrointestinal Disorders 5.3 (2022): 02-04.
Copyright: © 2022 SS Suleimanova., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.